Geoffrey R Oxnard (Geoffrey Oxnard)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 35

Top Topics

Tyrosine Kinase

Radical Prostatectomy

Circulating Tumor

Top Venues

JCO precision oncology

Clinical cancer research : an official journal of the American Association for Cancer Research

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Miles C Andrews, Gerald Li, Ryon P Graf, Virginia A Fisher, Jerry Mitchell, Ali Aboosaiedi, Harriet O'Rourke, Mark Shackleton, Mahesh Iddawela, Geoffrey R Oxnard, Richard S P Huang
Predictive Impact of Tumor Mutational Burden on Real-World Outcomes of First-Line Immune Checkpoint Inhibition in Metastatic Melanoma. JCO precision oncology 8 (2024)
Christian D Rolfo, Russell W Madison, Lincoln W Pasquina, Derek W Brown, Yanmei Huang, Jason D Hughes, Ryon P Graf, Geoffrey R Oxnard, Hatim Husain
Measurement of ctDNA Tumor Fraction Identifies Informative Negative Liquid Biopsy Results and Informs Value of Tissue Confirmation. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (11) (2024)
Jeff Yorio, Katherine T Lofgren, Jessica K Lee, Khaled Tolba, Geoffrey R Oxnard, Alexa B Schrock, Richard S P Huang, Lorraine Brisbin
Association of Timely Comprehensive Genomic Profiling With Precision Oncology Treatment Use and Patient Outcomes in Advanced Non-Small-Cell Lung Cancer. JCO precision oncology 8 (2024)
Alessandro Russo, Jessica K Lee, Lincoln W Pasquina, Marzia Del Re, Holli H Dilks, Karthikeyan Murugesan, Russell W Madison, Yi Lee, Alexa B Schrock, Leah A Comment, Martin Dietrich, Geoffrey R Oxnard, Christian D Rolfo
Liquid Biopsy of Lung Cancer Before Pathological Diagnosis Is Associated With Shorter Time to Treatment. JCO precision oncology 8 (2024)
Alessandro Russo, Jessica K Lee, Lincoln W Pasquina, Marzia Del Re, Holli H Dilks, Karthikeyan Murugesan, Russell W Madison, Yi Lee, Alexa B Schrock, Leah A Comment, Martin Dietrich, Geoffrey R Oxnard, Christian D Rolfo
Liquid Biopsy of Lung Cancer Before Pathological Diagnosis Is Associated With Shorter Time to Treatment. JCO precision oncology 8 (2024)
Jeff Yorio, Katherine T Lofgren, Jessica K Lee, Khaled Tolba, Geoffrey R Oxnard, Alexa B Schrock, Richard S P Huang, Lorraine Brisbin
Association of Timely Comprehensive Genomic Profiling With Precision Oncology Treatment Use and Patient Outcomes in Advanced Non-Small-Cell Lung Cancer. JCO precision oncology 8 (2024)
Alessandro Russo, Jessica K Lee, Lincoln W Pasquina, Marzia Del Re, Holli H Dilks, Karthikeyan Murugesan, Russell W Madison, Yi Lee, Alexa B Schrock, Leah A Comment, Martin Dietrich, Geoffrey R Oxnard, Christian D Rolfo
Liquid Biopsy of Lung Cancer Before Pathological Diagnosis Is Associated With Shorter Time to Treatment. JCO precision oncology 8 (2024)
Christian D Rolfo, Russell W Madison, Lincoln W Pasquina, Derek W Brown, Yanmei Huang, Jason D Hughes, Ryon P Graf, Geoffrey R Oxnard, Hatim Husain
Measurement of ctDNA Tumor Fraction Identifies Informative Negative Liquid Biopsy Results and Informs Value of Tissue Confirmation. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Christian D Rolfo, Russell W Madison, Lincoln W Pasquina, Derek W Brown, Yanmei Huang, Jason D Hughes, Ryon P Graf, Geoffrey R Oxnard, Hatim Husain
Measurement of ctDNA Tumor Fraction Identifies Informative Negative Liquid Biopsy Results and Informs Value of Tissue Confirmation. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (11) (2024)
Jeff Yorio, Katherine T Lofgren, Jessica K Lee, Khaled Tolba, Geoffrey R Oxnard, Alexa B Schrock, Richard S P Huang, Lorraine Brisbin
Association of Timely Comprehensive Genomic Profiling With Precision Oncology Treatment Use and Patient Outcomes in Advanced Non-Small-Cell Lung Cancer. JCO precision oncology 8 (2024)
Christian D Rolfo, Russell W Madison, Lincoln W Pasquina, Derek W Brown, Yanmei Huang, Jason D Hughes, Ryon P Graf, Geoffrey R Oxnard, Hatim Husain
Measurement of ctDNA Tumor Fraction Identifies Informative Negative Liquid Biopsy Results and Informs Value of Tissue Confirmation. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (11) (2024)
Julia Coelho França Quintanilha, Ryon P Graf, Geoffrey R Oxnard
BRAF V600E and RNF43 Co-mutations Predict Patient Outcomes With Targeted Therapies in Real-World Cases of Colorectal Cancer. The oncologist (2023)
Geoffrey R Oxnard, Ruthia Chen, Jennifer C Pharr, Diane R Koeller, Arrien A Bertram, Suzanne E Dahlberg, Irene R Rainville, Kate P Shane-Carson, Kelly A Taylor, Alicia Sable-Hunt, Lynette M Sholl, Craig C Teerlink, Alun Thomas, Lisa Anne Cannon-Albright, André P Fay, Patricia Ashton-Prolla, Hao Yang, Mary M Salvatore, Bonnie J Addario, Pasi A Janne, David P Carbone, Georgia L Wiesner, Judy E Garber
Germline EGFR mutations and familial lung cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Julia Rotow, Jyoti D Patel, Matthew P Hanley, Helena Alexandra Yu, Mark M Awad, Jonathan Wade Goldman, Hovav Nechushtan, Matthias Scheffler, Allen Chung-Cheng Huang, Senthil Rajappa, Guilherme Harada, Sarah Clifford, Alison D Santucci, Laura Silva, Rebecca Tupper, Geoffrey R Oxnard, Jennifer Kherani, Alexander E Drilon
Osimertinib and selpercatinib efficacy, safety, and resistance in a multicenter, prospectively treated cohort of EGFR-mutant and RET fusion-positive lung cancers. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Pashtoon Murtaza Kasi, Jessica K Lee, Lincoln W Pasquina, Brennan Decker, Pierre Vanden Borre, Dean C Pavlick, Justin M Allen, Christine Parachoniak, Julia Coelho França Quintanilha, Ryon P Graf, Alexa B Schrock, Geoffrey R Oxnard, Christine M Lovly, Hanna Tukachinsky, Vivek Subbiah
Circulating tumor DNA enables sensitive detection of actionable gene fusions and rearrangements across cancer types. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Julia C F Quintanilha, Michael H Storandt, Ryon P Graf, Gerald Li, Rachel B Keller, Douglas I Lin, Jeffery S Ross, Richard S P Huang, Alexa B Schrock, Geoffrey R Oxnard, Sakti Cjakrabarti, Amit Mahipal
Tumor Mutational Burden in Real-World Patients With Pancreatic Cancer: Genomic Alterations and Predictive Value for Immune Checkpoint Inhibitor Effectiveness. JCO precision oncology 7 (2023)
Felipe Batalini, Russell W Madison, Ethan S Sokol, Dexter X Jin, Kuei-Ting Chen, Brennan Decker, Dean C Pavlick, Garrett M Frampton, Gerburg M Wulf, Judy E Garber, Geoffrey R Oxnard, Alexa B Schrock, Nadine M Tung
Homologous Recombination Deficiency Landscape of Breast Cancers and Real-World Effectiveness of Poly ADP-Ribose Polymerase Inhibitors in Patients With Somatic BRCA1 / 2 , Germline PALB2 , or Homologous Recombination Deficiency Signature. JCO precision oncology 7 (2023)
Jhanelle E Gray, Myung-Ju Ahn, Geoffrey R Oxnard, Frances A Shepherd, Fumio Imamura, Ying Cheng, Isamu Okamoto, Byoung Chul Cho, Meng-Chih Lin, Yi-Long Wu, Margarita Majem Tarruella, Oliver Gautschi, Michael J Boyer, Krishna C Bulusu, Aleksandra A Markovets, J Carl Barrett, Rachel Hodge, Astrid McKeown, Ryan J Hartmaier, Juliann Chmielecki, Vassiliki A Papadimitrakopoulou, Suresh R Ramalingam
Early Clearance of Plasma Epidermal Growth Factor Receptor Mutations as a Predictor of Outcome on Osimertinib in Advanced Non-Small Cell Lung Cancer; Exploratory Analysis from AURA3 and FLAURA. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Bruna Pellini, Russell W Madison, Merrida Childress, Shoshana T Miller, Ole V Gjoerup, Jason Cheng, Richard S P Huang, Michael Krainock, Pratyush Gupta, Wei Zou, David S Shames, Solomon Moshkevich, Marcus Ballinger, Minetta C Liu, Amanda G Young, Minu K Srivastava, Geoffrey R Oxnard, Mark A Socinski
Circulating Tumor DNA Monitoring on Chemo-immunotherapy for Risk Stratification in Advanced Non-Small Cell Lung Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Jay A Moore, Kuei-Ting Chen, Russell W Madison, Justin Y Newberg, Zoe Fleischmann, Shuoguo Wang, Radwa Sharaf, Karthikeyan Murugesan, Bernard J Fendler, Jason Hughes, Alexa B Schrock, Priti S Hegde, Geoffrey R Oxnard, David Fabrizio, Garrett M Frampton, Emmanuel S Antonarakis, Ethan S Sokol, Dexter X Jin
Pan-Cancer Analysis of Copy-Number Features Identifies Recurrent Signatures and a Homologous Recombination Deficiency Biomarker to Predict Poly (ADP-Ribose) Polymerase Inhibitor Response. JCO precision oncology 7 (2023)
Alexander Chehrazi-Raffle, Hanna Tukachinsky, Eamon Toye, Smruthy S Sivakumar, Alexa B Schrock, Hannah E Bergom, Hedyeh Ebrahimi, Sumanta Kumar Pal, Tanya Barauskas Dorff, Archana M Agarwal, Brandon A Mahal, Geoffrey R Oxnard, Justin H Hwang, Emmanuel S Antonarakis
Unique spectrum of activating BRAF alterations in prostate cancer. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Julia Coelho França Quintanilha, Ryon P Graf, Geoffrey R Oxnard
BRAF V600E and RNF43 Co-mutations Predict Patient Outcomes With Targeted Therapies in Real-World Cases of Colorectal Cancer. The oncologist 28 (3) (2023)
Kristopher R Bosse, Anna Maria Giudice, Maria V Lane, Brendan McIntyre, Patrick M Schürch, Guillem Pascual-Pasto, Samantha N Buongervino, Sriyaa Suresh, Alana Fitzsimmons, Adam Hyman, Maria Gemino-Borromeo, Jennifer Saggio, Esther R Berko, Alexander A Daniels, Jennifer Stundon, Megan Friedrichsen, Xin Liu, Matthew L Margolis, Marilyn M Li, Marni Brisson Tierno, Geoffrey R Oxnard, John M Maris, Yael P Mosse
Serial Profiling of Circulating Tumor DNA Identifies Dynamic Evolution of Clinically Actionable Genomic Alterations in High-Risk Neuroblastoma. Cancer discovery 12 (12) (2022)
Amado J Zurita, Ryon P Graf, Guillermo Villacampa, Kira Raskina, Ethan S Sokol, Dexter Jin, Emmanuel S Antonarakis, Gerald Li, Richard S P Huang, Irene Casanova-Salas, Ana Vivancos, Joan Carles, Jeffery S Ross, Alexa B Schrock, Geoffrey R Oxnard, Joaquin Mateo
Genomic Biomarkers and Genome-Wide Loss-of-Heterozygosity Scores in Metastatic Prostate Cancer Following Progression on Androgen-Targeting Therapies. JCO precision oncology 6 (2022)
Ryon P Graf, Virginia Fisher, James Creeden, Alexa B Schrock, Jeffery S Ross, Halla Nimeiri, Geoffrey R Oxnard, Samuel J Klempner
Real-world Validation of TMB and Microsatellite Instability as Predictive Biomarkers of Immune Checkpoint Inhibitor Effectiveness in Advanced Gastroesophageal Cancer. Cancer research communications 2 (9) (2022)
Hope S Rugo, Kira Raskina, Alexa B Schrock, Russell W Madison, Ryon P Graf, Ethan S Sokol, Smruthy S Sivakumar, Jessica K Lee, Virginia A Fisher, Geoffrey R Oxnard, Hanna Tukachinsky
Biology and targetability of the extended spectrum of PIK3CA mutations (PIK3CAm) detected in breast carcinoma. Clinical cancer research : an official journal of the American Association for Cancer Research (2022)
Ibiayi Dagogo-Jack, Geoffrey R Oxnard, Makenzi Evangelist, Subba R Digumarthy, Jessica J Lin, Justin F Gainor, John F Murphy, Michael S Rabin, Rebecca S Heist, Alona Muzikansky, Alice T Shaw
Phase II Study of Lorlatinib in Patients With Anaplastic Lymphoma Kinase-Positive Lung Cancer and CNS-Specific Relapse. JCO precision oncology 6 (2022)
Liangliang Zhang, Omar Hamdani, Ole V Gjoerup, Cheryl Cho-Phan, Jeremy Snider, Emily H Castellanos, Halla Nimeiri, Garrett M Frampton, Jeffrey M Venstrom, Geoffrey R Oxnard, Samuel J Klempner, Alexa B Schrock
ERBB2 Copy Number as a Quantitative Biomarker for Real-World Outcomes to Anti-Human Epidermal Growth Factor Receptor 2 Therapy in Advanced Gastroesophageal Adenocarcinoma. JCO precision oncology 6 (2022)
Hatim Husain, Dean C Pavlick, Bernard J Fendler, Russell W Madison, Brennan Decker, Ole V Gjoerup, Christine A Parachoniak, Margaret E McLaughlin-Drubin, Rachel L Erlich, Alexa B Schrock, Garrett M Frampton, Meghna Das Thakur, Geoffrey R Oxnard, Hanna Tukachinsky
Tumor Fraction Correlates With Detection of Actionable Variants Across > 23,000 Circulating Tumor DNA Samples. JCO precision oncology 6 (2022)
Kim N Chi, Alan Barnicle, Caroline Sibilla, Zhongwu Lai, Claire Corcoran, J Carl Barrett, Carrie A Adelman, Ping Qiu, Ashley D Easter, Simon Dearden, Geoffrey R Oxnard, Archana M Agarwal, Arun A Azad, Johann S de Bono, Joaquin Mateo, David Olmos, Antoine Thiery-Vuillemin, Elizabeth A Harrington
Detection of BRCA1, BRCA2, and ATM Alterations in Matched Tumor Tissue and Circulating Tumor DNA in Patients with Prostate Cancer Screened in PROfound. Clinical cancer research : an official journal of the American Association for Cancer Research (2022)
Ryon P Graf, Virginia Fisher, Richard S P Huang, Omar Hamdani, Ole V Gjoerup, Jennifer Stanke, James Creeden, Mia A Levy, Geoffrey R Oxnard, Shilpa Gupta
Tumor Mutational Burden as a Predictor of First-Line Immune Checkpoint Inhibitor Versus Carboplatin Benefit in Cisplatin-Unfit Patients With Urothelial Carcinoma. JCO precision oncology 6 (2022)
Umang Swami, Ryon P Graf, Roberto H Nussenzveig, Virginia A Fisher, Hanna Tukachinsky, Alexa B Schrock, Gerald Li, Jeffery S Ross, Nicolas Sayegh, Nishita Tripathi, Vinay M Thomas, Geoffrey R Oxnard, Emmanuel S Antonarakis, Archana M Agarwal
SPOP Mutations as a Predictive Biomarker for Androgen Receptor Axis-Targeted Therapy in De Novo Metastatic Castration-Sensitive Prostate Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 28 (22) (2022)
Michael L Cheng, Jessica K Lee, Rachit Kumar, Harry Klein, Kira Raskina, Alexa B Schrock, Kesi S Michael, Tali Mazor, Ethan Cerami, Geoffrey R Oxnard, David R Liu, Himisha Beltran, Lynette M Sholl, Mizuki Nishino, Pasi A Janne
Response to MEK Inhibitor Therapy in MAP2K1 ( MEK1 ) K57N Non-Small-Cell Lung Cancer and Genomic Landscape of MAP2K1 Mutations in Non-Small-Cell Lung Cancer. JCO precision oncology 6 (2022)
Catherine B Meador, Marina S D Milan, Emmy Y Hu, Mark M Awad, Michael S Rabin, Cloud P Paweletz, Ryan Hartmaier, Gianluca Laus, Geoffrey R Oxnard
High Sensitivity of Plasma Cell-Free DNA Genotyping in Cases With Evidence of Adequate Tumor Content. JCO precision oncology 5 (2021)
Michael L Cheng, Christie J Lau, Marina S D Milan, Julianna G Supplee, Jonathan W Riess, Penelope A Bradbury, Pasi A Jänne, Geoffrey R Oxnard, Cloud P Paweletz
Plasma ctDNA Response Is an Early Marker of Treatment Effect in Advanced NSCLC. JCO precision oncology 5 (2021)